SmartPACS has unveiled a new radiology information system that it says will solve common integration problems.
SmartPACS has unveiled a new radiology information system that it says will solve common integration problems.
The RIS represents a new level of integration for SmartPACS, a New Jersey company that has focused on the smaller segment of the U.S. PACS market. Combined with the company's new orthopedic offering, it will operate through a single database, avoiding problems associated with combining multiple databases under a single RIS, according to David W. Parker, president of SmartPACS.
"Right now, with integration, people are spending 25% of their time finding lost cases, dealing with mislabeled data, and dealing with interface problems," Parker said.
Many of these integration problems can be avoided by using a single database.
The new Web-based system provides single log-on access to both RIS and PACS through a Web server. Its shared database expedites the instantaneous transfer of data between the two systems, streamlining operations and eliminating potential for errors, according to the company. Overall costs for an integrated system will be lower than if a RIS and a PACS were acquired individually, because the overlapping duplication of some equipment, installation costs for two systems instead of one, and reduced maintenance fees will all benefit the customer.
The new orthopedic offering allows the PACS to incorporate templates from five vendors for orthopedic planning. Because it is Web-based, the templates can be remotely accessed.
SmartPACS, working with its software development partner, South Korea-based Infinitt, is also developing brain subtraction and vessel analysis features to its integrated 3D interpretation system. The new capabilities will be available in the second quarter of next year, Parker said.
The 3D system, dubbed Rapida, is already available through SmartPACS and has been installed at many locations, including NYU Downtown Hospital, Saints Memorial Medical Center, and Warren Hospital. Rendering modes include 2D editing and segmentation, PRs, 3D shaded/unshaded volume rendering, and MIP/MinIP. The 3D software programs operate on any Intel-based workstation with Windows 2000 or XP.
Disclosure: SmartPACS is the sponsor of this year's Diagnostic Imaging RSNA meeting Webcast.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.